Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
September 21, 2005
Killer genes in pancreatic cancer therapy
P Fogar, E Greco, D Basso, et al.
Lupus
|
August 11, 2006
Insights in the laboratory diagnosis of celiac disease
D Basso, G Guariso, P Fogar, et al.
The International Journal of Biological Markers
|
October 1, 1995
Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art
M Plebani, D Basso, M P Panozzo, et al.
European Journal of Clinical Investigation
|
December 1, 1992
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases
D Basso, T Meggiato, C Fabris, et al.
Anticancer Research
|
March 1, 1997
Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias
P Fogar, D Basso, C Pasquali, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1995
Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes
D Basso, M Plebani, P Fogar, et al.
Minerva Gastroenterologica E Dietologica
|
April 1, 1992
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis]
P Scalon, F Di Mario, T Meggiato, et al.
Oncology
|
November 1, 1993
Clinical utility of TPS, TPA and CA 19-9 measurement in pancreatic cancer
M Plebani, D Basso, G Del Favero, et al.
Helicobacter
|
December 22, 1999
Effect of cagA status on the sensitivity of enzyme immunoassay in diagnosing Helicobacter pylori-infected children
M Plebani, G Guariso, P Fogar, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology
|
January 1, 1990
Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer
C Fabris, D Basso, T Meggiato, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
September 21, 2005
Killer genes in pancreatic cancer therapy
P Fogar, E Greco, D Basso, et al.
Lupus
|
August 11, 2006
Insights in the laboratory diagnosis of celiac disease
D Basso, G Guariso, P Fogar, et al.
The International Journal of Biological Markers
|
October 1, 1995
Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art
M Plebani, D Basso, M P Panozzo, et al.
European Journal of Clinical Investigation
|
December 1, 1992
Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases
D Basso, T Meggiato, C Fabris, et al.
Anticancer Research
|
March 1, 1997
Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias
P Fogar, D Basso, C Pasquali, et al.
International Journal of Clinical & Laboratory Research
|
January 1, 1995
Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes
D Basso, M Plebani, P Fogar, et al.
Minerva Gastroenterologica E Dietologica
|
April 1, 1992
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis]
P Scalon, F Di Mario, T Meggiato, et al.
Oncology
|
November 1, 1993
Clinical utility of TPS, TPA and CA 19-9 measurement in pancreatic cancer
M Plebani, D Basso, G Del Favero, et al.
Helicobacter
|
December 22, 1999
Effect of cagA status on the sensitivity of enzyme immunoassay in diagnosing Helicobacter pylori-infected children
M Plebani, G Guariso, P Fogar, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology
|
January 1, 1990
Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer
C Fabris, D Basso, T Meggiato, et al.
Page
of 5